Merit Financial Group’s Agios Pharmaceuticals AGIO Stock Holding History

Merit Financial Group’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$206K	Buy	+5,556	New	+$169K	﹤0.01%	2101

Other funds holding AGIO

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

CHC

City Holding Co Charleston, West Virginia $884M AUM 27.52% 1-Year Est. Return

Merit Financial Group's AGIO Position: Q2 2026 in Review

Merit Financial Group opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 5,556 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #2101 among its holdings.

21 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

Merit Financial Group held 5,556 shares of Agios Pharmaceuticals worth $206K as of Q2 2026.
Agios Pharmaceuticals was a new Merit Financial Group position in Q2 2026.
Agios Pharmaceuticals made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2101 holding.
21 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.